Escriber.com - Home of Wiley interface

One of these statements about COCs is false – which is it?
- A COC containing the progestogendesogestrel is classed as ‘progestogen dominant’
- Drospirenone is an antiandrogen with very mild diuretic activity
- Oestradiolvalerate is metabolised to 17-beta-oestradiol, the same hormone that is produce by the ovaries
- If one Qlaira pill is missed in the first 24 days of the pack, additional contraceptive measures should be taken for the next nine days
Which one of these statements is false?
- The principal mode of action of a COC is to inhibit ovulation by suppressing folliculogenesis
- The failure rate associated with typical use of a COC may be up to 8 per 100 woman-years of use
- The main problem contributing to contraceptive failure with COCs is missing pills in the middle of the cycle
- Noncontraceptive benefits of COCs include a reduction in ovarian cysts
Which one of these statements about the risks associated with COCs is false?
- COCs are relatively contraindicated in women with a positive first-degree family history of venous thromboembolism even if a thrombophilia screen is negative
- In women with risk factors for arterial disease, the increased risk of myocardial infarction is significant with oestrogen-dominant COCs and may be less with progestogen-dominant COCs
- Mild hypertension is not an absolute contraindication to COCs in the absence of other risk factors
- Women with a family history of breast cancer can use COCs but should be counselled about the increased background risk
One of these statements about drug interactions with COCs is false – which one?
- Alternative contraceptive methods should be considered for women taking enzyme-inducing drugs
- For a woman taking an enzyme-inducing drug, the minimum effective dose of ethinyloestradiol in a COC is 75µg
- The efficacy of a COC in a woman taking an enzyme-inducing drug can be increased by shortening the pill-free interval to four days or omitting it entirely
- When starting long-term treatment with a tetracycline in a women taking a COC, additional contraceptive measures should be taken for three weeks
Which one of these statements about progestogen-only pills (POPs) is false?
- The risk of breast cancer during use is uncertain
- Ovulation is inhibited in 15–40 per cent of cycles
- Menstrual irregularities are common
- Unlike COCs, hepatic enzyme-inducing drugs do not reduce the effectiveness of POPs
Regarding the place of COCs and POPs in contraception, which one of these statements is false?
- A review should be scheduled after three months to assess the method and consider if a change is necessary
- POPs are less effective than COCs in women aged over 35
- The combined contraceptive patch (Evra) and the combined vaginal ring (NuvaRing) should be considered if adherence is an issue
- Extended cycle and continuous COCs improve menstrual-associated symptoms compared with cyclical regimens despite an initial increase in unscheduled bleeding

Escriber.com - Home of Wiley interface

Wiley-Blackwell Titles

Advertising and Sponsorship

Search the Site